Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness - Scorecard - MDSpire

Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness

  • May 7, 2026

  • 2 min

Share

Clinical Scorecard: Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness

At a Glance

CategoryDetail
ConditionPandemic-prone viral infections
Key MechanismsMolecular fingerprinting of biological samples using Raman spectroscopy and its enhanced variants.
Target PopulationIndividuals at risk of viral infections, including those with influenza, SARS-CoV-2, Ebola, and dengue.
Care SettingClinical diagnostics and virology research.

Key Highlights

  • Raman spectroscopy offers rapid, label-free insight into viruses and host responses.
  • Enhanced techniques like SERS, TERS, and CARS improve sensitivity and resolution.
  • Demonstrated rapid detection of influenza and high accuracy in SARS-CoV-2 identification.
  • Research focus is skewed towards accessible viruses, neglecting high-risk pathogens.
  • Technical barriers include weak signal intensity and fluorescence interference.

Guideline-Based Recommendations

Diagnosis

  • Utilize Raman spectroscopy for rapid detection of viral infections.

Management

  • Integrate enhanced Raman techniques for improved diagnostic accuracy.

Monitoring & Follow-up

  • Employ Raman-based methods for real-time monitoring of virus-host interactions.

Risks

  • Address technical limitations such as weak signal intensity and regulatory hurdles.

Patient & Prescribing Data

Patients suspected of viral infections, particularly during outbreaks.

Raman spectroscopy can facilitate early diagnosis and treatment decisions.

Clinical Best Practices

  • Standardize Raman spectroscopy protocols to enhance reproducibility.
  • Develop AI-driven analysis tools to streamline data interpretation.
  • Expand research on underexplored high-risk pathogens.

References

Original Source(s)

Related Content